BX:NYSEBlackstone Inc. Analysis

Blackstone’s stock is trading at $110.65, well below its 20‑day SMA of $121.3 and the 50‑day SMA of $139.2, with an RSI of 31 indicating oversold conditions. Technical indicators such as a bearish MACD and a price hovering just above the $105 support level suggest limited upside in the near term, while the 30‑day volatility of roughly 44% and a beta above 1.5 highlight heightened market sensitivity. The dividend yield of 4.29% is attractive, but a payout ratio exceeding 120% raises concerns about sustainability. Moreover, the DCF‑derived fair value of $91 is markedly below the current price, implying the stock is overvalued on a valuation basis.
Fundamentally, Blackstone delivered a 50% revenue surge YoY and its forward PE has compressed to 14x, supporting a strong earnings growth narrative. Recent strategic moves, including the launch of a public vehicle to acquire AI data centers and a $10 billion debt deal in women’s healthcare, bolster the growth case. Analysts collectively rate the stock as a “buy” with a median target of $161, indicating a potential upside of over 40% from today’s level. However, the recent Blue Owl redemption freeze and the high leverage profile introduce credit‑related risk that could temper long‑term returns.